Regulators Discuss Plans to Streamline Europe’s Drug Approval Process at 2026 RAPS Convergence
read at raps ↗RegulatoryNeutral
A panel of European regulators gathered at the 2026 RAPS Convergence in Charlotte, North Carolina to discuss ongoing initiatives aimed at simplifying the continent’s regulatory framework.
The officials outlined plans to harmonize requirements across member states, cut redundant steps, and create more predictable timelines for drug developers.
By making the approval pathway more streamlined, the regulators hope to enable sponsors to bring new medicines to European patients faster and with greater certainty.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Convergence: Regulators highlight efforts to streamline the European regulatory framework”
read at raps ↗
comments(0)
5-min edit window · permanent after that